Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about LILLY DRN
Recent news which mentions LILLY DRN
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
November 19, 2024
Tags
Health & Science
Dexcom Inc
Healthy Returns
From
CNBC.com News
Cramer's Lightning Round: Eli Lilly is a buy
November 18, 2024
Tags
Markets
Stock Picks
Market Outlook
From
CNBC.com News
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
November 15, 2024
Tags
stocks
General Mills Inc
THE JM SMUCKDRN
From
CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
November 12, 2024
Tags
Health & Science
Pharmaceuticals
Amgen Inc
From
CNBC.com News
‘Two-stocks’ are better than one? Repacking ‘pair trades'
November 09, 2024
Tags
LILLY DRN
Investment strategy
Yum! Brands Inc
From
CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
November 08, 2024
Tags
Biotech and Pharmaceuticals
Social issues
Novo Nordisk A/S
From
CNBC.com News
Jim Cramer says CEOs must properly explain the bad news in every quarter
October 30, 2024
Tags
stocks
Stock Picks
Markets
From
CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
October 30, 2024
Tags
US: News
Novo Nordisk A/S
Health & Science
From
CNBC.com News
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still fell short
October 30, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Business News
From
CNBC.com News
Jim Cramer's top 10 things to watch in the stock market Wednesday
October 30, 2024
Tags
CNBC Investing Club: Analysis
Meta Platforms Inc
Breaking News: Markets
From
CNBC.com News
Eli Lilly stock tumbles 10% after missing estimates and slashing profit guidance
October 30, 2024
Tags
Companies
LILLY DRN
Business
From
CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
Tags
Amgen Inc
Lennar Corp
Pultegroup Inc
From
CNBC.com News
Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon
October 25, 2024
Tags
Business News
Meta Platforms Inc
Amazon/com Inc
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
Tags
US: News
Obesity
Novo Nordisk A/S
From
CNBC.com News
Cramer's Lightning Round: 'Wait for a pullback' with Eli Lilly
October 23, 2024
Tags
S&P 500
U/S/ Markets
Investing
From
CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
October 23, 2024
Tags
Amazon/com Inc
Social issues
Biotech and Pharmaceuticals
From
CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
October 23, 2024
Tags
Business
Pharmaceuticals
Health & Science
From
CNBC.com News
KKM Financial's Essential 40 stock fund is now an ETF
October 21, 2024
Tags
LILLY DRN
Markets
Investment strategy
From
CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
October 15, 2024
Tags
Biotech and Pharmaceuticals
LILLY DRN
Social issues
From
CNBC.com News
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
October 15, 2024
Tags
Business News
Biotech and Pharmaceuticals
Europe: Top News And Analysis
From
CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
October 11, 2024
Tags
Biotech and Pharmaceuticals
Europe News
Biotechnology
From
CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
October 03, 2024
Tags
General Motors Co
JPMorgan Chase & Co
JD/Com Inc
From
CNBC.com News
5 things to know before the stock market opens Thursday
October 03, 2024
Tags
Technology
Business
LILLY DRN
From
CNBC.com News
Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
October 02, 2024
Tags
LILLY DRN
Health & Science
Business
From
CNBC.com News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.